Login

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q3 FY2025
As of Sep 30, 2025
Q2 FY2025
As of Jun 30, 2025
Q1 FY2025
As of Mar 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q3 FY2024
As of Sep 30, 2024
Q2 FY2024
As of Jun 30, 2024
Q1 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Assets
Cash and cash equivalents
Accounts receivable, net of allowances of $0 and $22 as of September 30, 2025 and December 31, 2024, respectively
Inventory, net
Prepaid assets
Other current assets
Total current assets
Property and equipment, net
Film costs, net
Other assets
Deferred tax asset, net
Total assets
Liabilities and Equity
Accounts payable
Accrued expenses and other current liabilities
Deferred revenue
Current portion of long-term debt and lease liabilities
Current portion of lease liabilities
Total current liabilities
Long-term debt and lease liabilities, net of current portion
Deferred revenue, net of current portion
Other noncurrent liabilities
Deferred tax liability, net
Total liabilities
Common Stock
Series A Common Stock
Series B Common Stock
Additional paid-in capital
Retained earnings
Noncontrolling interests
Total equity
Total liabilities and equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support